Close Menu

NEW YORK – After being forced to keep its sales teams working from home and seeing a decline in sales of its cancer tests because of the COVID-19 pandemic, Exact Sciences is now sinking more resources into telehealth solutions, like encouraging patients to order its Cologuard colorectal cancer test online. The company is betting that the pandemic will permanently change how patients interact with their healthcare providers and believes it can step in as the diagnostic provider of the future.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.